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IF a non-toxic compound could be found which would concentrate selectively
in tumour tissue and which would also increase the sensitivity of cells towards
X-rays, it might be of use in the treatment of malignancy. This search for a
radio-sensitizer has been the concern of these laboratories for a number of years,
and initial studies have been mainly concerned with tetrasodium 2-methyl-I: 4-
naphthohydroquinone diphosphate (I).
The compound has several biological actions of interest. It is a synthetic
Vitamin K substitute (Synkavit) by virtue of its ready dephosphorylation and
oxidation to 2-methyl-1: 4-naphthoquinone, but it also affects mitoses in cultures
of chick fibroblasts (Mitchell and Simon-Reuss, 1947). It increases the antimitotic
and chromosome fragmentation effects ofX-irradiation on tissue cultures (Mitchell
anid Simon-Reuss, 1947, 1952a, 1952b) and also increases tumour retrogression
by X-rays in rats bearing a Walker carcinoma (Mitchell, 1954). A small but useful
increase in the survival time of patients undergoing X-ray therapy for inoperable
carcinoma of the lung has also been reported (Mitchell, 1953). Furthermore,
Mitchell (1954) has observed that after an injection of (I)into the rat, someinternal
organs, if dissected and treated with alkaline hydrogen peroxide, show a brilliant
yellow fluorescence in ultra-violet light; the fluorescence is especially strong on
the growing edge ofthe tumour. It seemed likely that this indicated local accumu-
lations of 2-methyl-I:4-naphthoquinone-2: 3-oxide (II) derived from (I).
Further information on possible selective concentration was therefore sought by
studying the metabolism of (I) labelled with 14C in the methyl group.
OP03 Na2 0
I CH CH
\0
OPO3Na, O
I Ii
METHODS AND MATERIALS
C(ounting.-A windowless methane flow counter operating in the proportional
region was used (Taylor and Sharpe, 1951).
Solutionsfor injection.-The compound (Andrews, Marrian and Maxwell, 1956),
which was stored as the dry dibarium salt, was dissolved in a little water containing
a trace of hydrochloric acid and converted to a solution of the tetrasodium saltD. H. MARRIAN AND D. R. MAXWELL
by percolating through a small column of Dowex 50 (sodium form). If not used
at once, the solution was stored at 0° C. in a vial under nitrogen. The specific
activity of the compound was determined both by plating out aliquots of known
optical density (e= -5600 at 290mj/ in 0-01 N hydrochloric acid), or, after
dilution with carrier material, by wet oxidation to barium carbonate which was
counted and a self absorption factor applied. Both methods gave an activity of
1 83 x 105 cpm//tM. The radioactive purity of such solutions was determined
before use by counting sections of a paper chromatogram of a drop ofthe solution
run in saturated aqueous ammonium sulphate (80 vols.), 1M sodium acetate (20
vols.) and isopropanol (2 vols.). About 99 per cent of the activity was associated
with the main ultraviolet absorbing spot (Rf 0.55) and the remainder with traces
ofslow moving material. Autoradiography of the dried paper strip and estimation
ofthe amount ofblackening ofthe film gave a similar result but was less convenient.
Animalexperiments.-Laboratory stock albino malerats wereused. The tumour
bearing rats carried Walker 256 carcinoma used at the 2nd or 3rd passage from
an ascites tumour. The tumour was implanted subcutaneously in the left flank
some 10-days before the experiment and weighed 5-10 g. on the day ofinjection;
animals with small, rapidly growing tumours were selected. The compound
(5-10 mg.) was injected into the tail vein and the animal immediately put into
a perspex metabolism chamber connected when necessary to an apparatus for
collecting respired carbon dioxide in carbonate-free alkali (Mackenzie, Chandler,
Keller, Cross and du Vigneaud, 1949).
Preparation of the samples for analysis.-The animals were killed (chloroform)
in a closed chamber which was later rinsed with water, and the water added to
the urine sample. Immediately the animal was dead, blood was removed by
cardiac puncture, the internal organs dissected, placed in weighed specimen
tubes, and frozen in acetone/fCO2. The radioactivity in the carcass was determined
by homogenising the frozen carcass in 2N sodium hydroxide; aliquots of each
layer of the centrifuged homogenate were oxidised to barium carbonate. The
remainder of the solid material from the homogenate was dried and defatted by
washing with methanol and refluxing with methanol/chloroform'. If not analysed
at once, the samples were kept at 20°. Storage at this temperature for 3 weeks
did not affect the activity ofthe derived barium carbonate.
Analysis of tissues and blood samples.-Duplicate weighed samples (about
100 mg.) were quantitatively oxidised by the van Slyke-Folch reagent (Van Slyke,
1954) and the carbon dioxide isolated as barium carbonate under strictly standar-
dised conditions (Wick, Barnet and Ackerman, 1949). The whole of the barium
carbonate was plated out on an aluminium planchette, dried, weighed and counted
to a standard error ofless than 5 per cent. The activites of duplicate samples were
within 10 per cent of the mean value.
Investigation of the urine.-The total activity in the urine was determined by
plating out aliquots in infinitely thin layers. Two paper chromatographic separa-
tions were run, the solvents being (a) the one referred to above and (b) n-butanol
(3 vols.) and methanol (1 vol.) saturated with water containing a few drops of
acetic acid.
RESULTS AND DISCUSSION
Previous studies of the metabolism of tetrasodium 2-methyl-1: 4-naphtho-
hydroquinone diphosphate have given confused results. The fate, in rats, of
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intramuscular injections of the compound labelled with 32p has been studied by
Neukomm (1954) and his colleagues (Neukomm, Peguiron, Lerch and Richard,
1953) who showed that exchange occurred between the compound and the inor-
ganic phosphate pool. By extrapolation of their time curves, they deduced a
curve denoting fixation and excretion of the compound and showed that the
metabolism of the compound and of inorganic phosphate followed different and
distinguishable courses; fixation of the compound occurred mainly in metabolic-
allyactive organs andinthose concernedwith storage, detoxification and excretion.
However, Morrison and Crowley (1952) using the same label, concluded that the
phosphate groups were quickly split off and that the resulting activity was
distributed as inorganic phosphate. Since injected 2-14C-methyl-1 : 4-naphtho-
quinone can be excreted as the hydroquinone diphosphate (Jaques, Millar and
Spinks, 1954), injection of the phosphorus labelled hydroquinone diphosphate
can quickly give rise to unlabelled 2-methyl-1: 4-naphthoquinone which could
then be reduced and phosphorylated by the phosphate pool to give the original
injected compound with a much lower specific activity. These complications
do not arise with the 14C labelled compound, and the fixation and excretion of
tetrasodium 2-14C-methyl-1: 4-naphthohydroquinone diphosphate by the rat is
showninTable I. Theamountassociatedwith the bloodwasestimated byoxidising
a known volume to carbon dioxide and assuming that the total blood volume was
6-7 ml. per 100 g. body weight (Gartland and Koch, 1928). Only about 70 per
cent ofthe injected radioactivitywas recovered, and since the oxidation technique
TABLE I.-Recovery of radioactivity from a rat (237 g.) injected intravenously
(tail) with 5 mg. of tetrasodium 2-14C-methyl-1: 4-naphthohydroquinone
diphosphate and killed 1I hours later. Total injected activity 2.66 x 106 cpm.
Total activity Percentage of
Tissue. cpm. X 105. injected dose.
Urine . . . . . 867 . 326
Blood . . . . . . 0-65 . 244
Organs . . . . . . 080 . 3.0
CO2 . . . 0- 26 . 1*0
Faeces . . . . . . 0 . 0
Carcass homogenised in aq. NaOH:
(i) Solid . . . . . 3- 92 . 14.8
(ii) Liquid . . . . 4'3 . 16-2
Totals . . .. 18-6 x 105 . 70%
The solid fraction of the carcass homogenate was dried and defatted and then contained a total
of 2 X 104 cpm. (about 1 per cent of the dose).
was better than 95 per cent effective, there remains about 25 per cent of the dose
unaccounted for. Efficient homogenising and sampling of the carcass was not
easy, and this may account for some of the loss. However, the recovery compares
well with the similar experiment using 2-14C-methyl-1 : 4-naphthoquinone where
only 50 per cent of the activity was accounted for (Jaques, Millar and Spinks,
1954). The occurrence of activity in the respired carbon dioxide is of interest
since it has been reported (Solvonuk, Jaques, Leddy, Trevoy and Spinks, 1952)
that 2-14C-methyl-1: 4-naphthoquinone was not oxidised to carbon dioxide by
the mouse; the low specific activity of the starting material available at that
time may explain this discrepancy. To confirm this oxidation, a 24 hourinvestiga-
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tion of respiratory carbon dioxide was carried out after a tumour bearing rat
had been given an intravenous injection of 8.5 mg. (I). The results are shown in
Fig. 1 while Fig. 2 shows the total activity respired by the rat over the 24 hour
period. It can be seen (Fig. 1) that there is a maximum both in the specific
activity and of the rate of respiraticn of carbon dioxide at about 2 hours after
injection, after which both values fall, then remain constant for the rest of the
experimental period-the respired activity being about 0-25 per cent of the dose
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FIG. 1.
L.H. Ordinate: cpm./gm. BaCO3 x 103.
R.H. Ordinate: C02 expiration rate in gm. BaCO3/hr.
Abcissa: Time in hours after injection.
Radioactivity in CO2 respired by the rat following an injection of 8-5 mg. tetrasodium
2-_4C-methyl-1: 4-naphthohydroquinone diphosphate.
Full curve: specific activity of respired CO2.
Broken curve: rate of respiration ofCO2.
Shaded areas denote periods when CO2 was collected.
per hour. These maxima could infer an initial period ofhigh intracellular concen-
tration in the tissue and would suggest that localisation of the compound did
occur to some extent. The later, steady respiration of activity shows that 2-14C-
methyl- : 4-naphthoquinone is also broken down to carbon dioxide.
The products excreted in the urine by the rat were investigated by paper
chromatography; results agreed with those previously reported for the meta-
bolism of 2-14C-methyl-L: 4-naphthoquinone (Jaques, Millar and Spinks, 1954).
The methanol/butanol solvent separated 3 active components from rat urine,
one having the position normally occupied by the injected compound (I). The
other two (Components A and B) corresponded with the glucuronide and sulphate
already described (Fig. 3 andTableII). (Jaques, Millar andSpinks; 1954; Rickert,
1944, 1951; Doisy, 1949). The ammonium sulphate system also indicated the
presence ofthe injected material but did not separate the other active components.
The excretion of (I) even 24 hours after injection did not, of course, indicate that
the compound had not undergone rapid dephosphorylation.
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TABLE II.-Percentage of the Total Radioactitvity in rat urine at intervals after
intravenous injection of 5 mg. (I). The components refer to the active peaks in
Fig. 3.
Fraction.
0-2 hours
2-6 hours
6-24 hours
Injected
Compound (I).
9.9
5.6
4.4
Component A.
63
71
72
Component B.
23.0
23.8
23*0
The distribution of the intravenously injected compound in the various
organs ofthe tumour bearing rat is shown in Table III in terms ofthe Differential
4.
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FIa. 2.
Ordinate: Percentage of injected radioactivity in respired CO2 following injection of 5 mg.
tetrasodium-2-14C-methyl-1 : 4-naphthohydroquinone diphosphate.
Abcissa: Time in hours after injection.
Absorption Ratio (cf. Moore, Tobin and Aub, 1943) (D.A.R.), a convenient means
ofstudying possible localisation of a compound in a tissue. The D.A.R. is defined
as
Observed activity/g. of tissue
Total injected activity/g. of total rat weight.
Thus, if a compound were uniformly distributed throughout the body and not
excreted, the D.A.R. of each tissue would be 1-0. Since excretion usually occurs,
the D.A.R. decreases with time. Moreover, since the technique of wet oxidation
was almost quantitative, the D.A.R. can also be calculated in terms of dry tissue
thus
Activity/g. BaCO3 from the tissue D.A.R. (dry tissue) = Total injected activity/g. BaCO3 from the whole rat
The mean BaCO3 equivalent of the whole rat was taken to be the same as for
muscle. These results are given in Table IV. Tables II, III and IV show that the
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compound concentrates in the organs concerned with Vitamin K function and
with detoxification and excretion. But, on a dry weight basis (Table IV) the
D.A.R. of tumour is several times higher than that of muscle, especially for short
periods after injection.
0
FIG. 3.
Ordinate: Radioactivity in cpm.
Abcissa: Fraction number: (each fraction represents 2 cm. of the chromatogram).
Distribution ofradioactivity along achromatogram ofurine excreted by a rat bearing aWalker
carcinoma during 2 hours following an injection of 5 mg. tetrasodium 2-14C-methyl-,: 4-
naphthohydroquinone diphosphate (Butanol/methanol system). The three peaks of
activity are, respectively, the injected compound (I), and two metabolites A and B (see
Table II).
It is probable that the figure found for the D.A.R. of the tumour is minimal
since the whole tumour tissue contains more stroma than tumour cells. Since
fluorescence studies indicated that nearly all the fluorescence arose from the
tumour cells and not from the stroma (Mitchell, 1954), this suggests that the
actual D.A.R. in the tumour cells must be much higher than that measured for
the tumour tissue as a whole.
These results add force to earlier indications that 2-14C-methyl-1: 4-naphtho-
hydroquinone bis (disodium phosphate) can eoncentrate in tumour tissue for short
periods and give hope that a compound may be developed with a similar but more
pronounced radiosensitizing effect possibly acting by virtue ofselective concentra-
tion in tumour tissue.
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TABLE III.-The 14C Content of Tissue Samples from Rats with The Walker
256 Carcinomafollowing Intravenous Injectionof5 to 10 mg. of14C-Compound I.
D.A.R. (wet tissue).
1 hour.
,- - 11 hours. 2 hours. 24 hours.
Rat No. . 14/1 21/1 17/1 18/1 1 !2
Tumour 03 0 24 0.21 0.095 0.12
Muscle . 0-15 0.11 0.05 0.093 0.10
Testis . 0-26 0.23 0.16 0-13 0.17
Kidney 2.0 2-1 1-1 0.67 0.46
Spleen . 03 0.24 0.16 0-12 0.11
Liver . 0-66 061 0-28 0-29 0 I8
Blood . . 0 67 0-53 0 37 0 27 0 12
(4.4%) (3.6%) (2.4%) (1.8%) (0-79%)
Urine . .. - 32% - 22%
Faeces . - - - - 5.3%
CO2 . . 0.01% - - 0.03% 5.9%
Percentages in the lower half of the table indicate percentage of the injected dose associated with
the blood and excreta.
TABLE IV.-The 14C Content of Tissue Samples from Rats with The Walker 256
Carcinomafollowing Intravenous Injection of 5 to 10 mg. of 14C-Compound I.
D.A.R. (dry tissue).
A_
1 hour.
A- I- - 1 hours. 2 hours. 24 hours.
Tumour . 044 0 37 0.36 0.11 0'18
Muscle . 013 0.10 0.06 0.08 0.16
Testis . . 043 0.42 0-27 0-23 0-28
Kidney . 1 7 1.9 1.3 0.65 0.42
Spleen . 0.31 0.22 0.18 0 13 0-12
Liver . . 0-58 045 0-26 0-23 0-17
SUMMARY
The metabolism of tetrasodium 2-14C-methyl-1 : 4-naphthohydroquinone
diphosphate has been studied in rats. About 30 per cent ofthe activity is excreted
in the urine within 90 minutes of injection and activity is also found in respired
carbon dioxide.
Measurement of the Differential Absorption Ratio of various internal organs
shows that, for short periods after injection, the compound concentrates more in
tumour tissue than in muscle, but that it also accumulates in organs concerned
with detoxification, excretion and Vitamin K function.
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